Gene Query: RAB11FIP5

Dataset Description Geneva Score
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 66.27
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 53.43
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 53.43
GATA3-mediated chromatin reprogramming in breast cancer cells 42.43
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 32.39
Primary human trophoblast from term placenta 31.5
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 31.05
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 29.24
TFAP2C signalling in human fibroblasts 26.15
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 25.16
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 24.99
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 21.61
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 21.23
Chromatin-informed inference of transcriptional programs in gynecologic cancers 21.23
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 20.5
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 20.5
STRIPAK directs PP2A activity to promote oncogenic transformation 20.4
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 19.68
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 19.59
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 19.34
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 19.31
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 18.36
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 18.29
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 17.3
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 17.21
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 17.21
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 17.07
RNA sequencing of GlyH-101-treated MCF-7 cell line 16.81
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 16.53
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 15.99
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 15.98
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 15.68
Differential analysis of gene regulation at transcript resolution by RNA-Seq 15.68
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 15.66
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 15.42
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 15.42
15.33
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 15.25
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 15.17
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 15.08
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 14.84
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 14.68
High level DNA repair gene expression in human ES cells 14.51
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 14.49
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 14.49
Genome-wide identification of cancer-specific alternative splicing in circRNA 14.21
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 14.16
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 13.99
snRNAs as regulators of alternative splicing 13.96
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 13.89
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 13.79
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 13.72
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 13.48
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 13.48
The role of FAM46C in myeloma cells 13.19
The role of FAM46C in myeloma cells [sequencing] 13.19
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 13.02
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 12.98
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 12.92
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 12.92
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 12.88
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 12.87
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 12.87
RNA-seq of human aneuploid cell lines with Trisomy 21 12.8
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 12.46
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 12.42
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 12.42
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 12.19
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 12.07
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 11.78
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 11.72
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 11.45
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 11.44
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 11.41
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 11.41
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 11.39
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 11.17
RNA-seq analysis of BAP1-depleted uveal melanoma cells 11.15
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 11.13
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 11.13
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 11.05
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 10.97
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 10.97
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 10.94
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 10.92
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 10.89
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 10.79
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 10.72
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 10.72
Inhibition of TNBC metastasis by Gpx1 10.51
RNA sequencing with KSHV infection and enrichment for circular RNAs 10.46
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 10.46
Universal alternative splicing of noncoding exons 10.44
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 10.41
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 10.38
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 10.37
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 10.35
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 10.22
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 10.13
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 10.05
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 10.03
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 10.03
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 9.97
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 9.92
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 9.83
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 9.8
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 9.75
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 9.61
Genome-wide chromatin analysis of Ewing sarcoma 9.58
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 9.58
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 9.52
mRNA-sequencing of breast cancer subtypes and normal tissue 9.32
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 9.31
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 9.15
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 9.14
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 9.14
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 9.13
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 9.13
Postnatal lipids drive hepatocyte maturation 9.11
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 9.08
Molecular Mechanisms of Endothelial Hyperpermeability 9.01
FOXD3 is a novel tumor suppressor in lung cancer 9.01
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 8.95
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 8.93
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 8.92
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 8.87
Differential gene expression profiles in imatinib-resistant cell lines 8.87
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 8.82
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 8.82
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 8.75
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 8.75
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 8.65
A role for ZNF598 in post-transcriptional gene regulation 8.59
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 8.57
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 8.55
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 8.46
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 8.46
Rorc disruption in human FG pancreatic cancer cells 8.44
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 8.42
DJ-1 is dispensable for human stem cell homeostasis 8.41
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 8.4
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 8.36
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 8.36
High-efficiency RNA-based reprogramming of human primary fibroblasts 8.29
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 8.28
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 8.26
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 8.21
In vitro modeling of human germ cell development using pluripotent stem cells 8.15
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 8.1
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 7.97
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 7.96
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 7.94
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 7.9
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 7.83
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 7.83
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 7.8
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 7.8
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 7.75
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 7.73
Small-molecule targeting of brachyury transcription factor addiction in chordoma 7.73
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 7.69
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 7.68
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 7.68
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 7.65
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 7.6
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 7.6
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 7.6
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 7.59
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 7.54
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 7.54
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 7.54
Next Generation Sequencing of human SMA and healthy control Motor Neurons 7.53
Co-transcriptional loading of RNA export factors shapes the human transcriptome 7.44
RNAseq of HEK293 cells after Chtop knockdown 7.44
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 7.37
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 7.37
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 7.37
Control of prostate tumour growth by the long non-coding RNA GHSROS 7.37
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 7.37
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 7.34
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 7.32
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 7.31
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 7.31
Neurofibroma 7.27
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 7.27
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 7.21
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 7.19
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 7.12
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 7.12
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 7.06
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 7.06
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 6.99
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 6.97
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 6.97
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 6.96
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 6.96
The regulartory role of ZCCHC24 in splicing machinery 6.95
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 6.94
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 6.93
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 6.92
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 6.92
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 6.92
MYCi975 regulates MYC target genes 6.91
Transcriptomic and gene ontology profiling of the human corneal cell types 6.91
Maturation of human iNSCs 6.9
Ebola virus (EBOV) infection of ARPE-19 cells 6.9
Gene expression profile of human placenta from T. Cruzi infected mothers 6.89
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 6.88
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 6.84
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 6.83
Global epigenomic reconfiguration during mammalian brain development 6.83
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 6.83
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 6.82
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 6.82
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 6.8
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 6.8
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 6.79
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 6.79
The MEF2B Regulatory Network 6.77
The MEF2B Regulatory Network - RNA-seq data 6.77
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 6.77
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 6.77
Gene expression changes associated with resistance to tagraxofusp (SL-401) 6.74
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 6.71
The cohesin complex prevents Myc-induced replication stress 6.71
RNA-sequencing in immortalized human mammary epithelial cells 6.65
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 6.65
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 6.64
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 6.64
Lysine benzoylation is a novel histone mark 6.61
Lysine benzoylation is a novel histone mark [RNA-seq] 6.61
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 6.61
Selective suppression of endothelial cytokine production by progesterone receptor 6.6
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 6.6
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 6.56
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 6.54
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 6.54
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 6.53
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 6.53
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 6.51
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 6.5
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 6.48
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 6.47
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 6.46
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 6.46
TOP2B disturbed the quality of human oocytes with advanced maternal age 6.41
A transcriptome dataset revealing the molecular features of breast cancer stem cells 6.37
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 6.35
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 6.35
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 6.26
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 6.23
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 6.23
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 6.2
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 6.19
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 6.18
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 6.14
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 6.13
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 6.09
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 6.08
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 6.07
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 6.0
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 5.99
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 5.96
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 5.96
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 5.95
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 5.95
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 5.92
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 5.91
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 5.91
Gene expression changes due to PARP knockdown in human cells 5.88
miR-93 Targets in Human Endothelial Cells 5.87
CSL 5.86
CSL RNA-Seq on HKC and SCC cell lines 5.86
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 5.83
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 5.81
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 5.81
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 5.79
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 5.73
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 5.73
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 5.73
Genetic-to-epigenetic Therapy for Pancreatic Cancer 5.7
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 5.7
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 5.69
The Genomic Landscape of Atypical Fibroxanthoma 5.61
EWS-Fli and LNC regulated genes in comparison to GFP samples 5.56
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 5.55
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 5.51
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 5.48
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 5.48
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 5.45
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 5.45
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 5.44
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 5.39
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 5.38
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 5.34
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 5.32
Toxoplasma gondii infection of human retinal pigment epithelial cells 5.28
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 5.26
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 5.25
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 5.2
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 5.17
4sU-seq of HFF exposed to salt and heat stress 5.16
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 5.09
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 5.04
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 5.03
Noncoding regions are the main source of targetable tumor-specific antigens 5.03
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 5.02
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 5.0
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 4.98
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 4.91
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 4.86
RNA-seq analysis of the human fetal kidney. 4.85
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 4.77
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 4.77
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 4.74
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 4.74
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 4.74
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 4.72
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 4.71
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 4.67
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 4.67
circRNA-sequencing 4.66
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 4.63
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 4.56
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 4.54
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 4.53
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 4.52
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 4.51
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 4.48
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 4.45
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 4.4
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 4.32
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 4.31
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 4.29
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 4.28
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 4.28
RNA sequencing of human pancreatic cancer cell lines 4.26
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 4.22
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 4.22
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 4.16
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 4.13
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 4.1
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 4.09
NKX2.2 4.09
Effect of nuclear IL-33 on gene expression 4.08
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 4.08
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 3.99
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 3.99
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 3.97
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 3.94
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 3.9
CD86 regulates a pro-survival signal in myeloma cells 3.86
X-Ray induced DNA-Hydroxymethylation changes 3.85
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 3.82
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 3.82
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 3.78
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 3.78
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 3.74
Investigate A2M treatment on human prostate cancer and mouse liver 3.72
Investigate A2M treatment on human prostate cancer xenograft in mice 3.72
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 3.71
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 3.71
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 3.71
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 3.69
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 3.69
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 3.65
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 3.64
Fusion discovery in breast cancer cell line 3.62
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 3.56
RNA sequencing of mechanically strained NHEKs and control NHEKs 3.52
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 3.43
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 3.41
Clinker: visualizing fusion genes detected in RNA-seq data 3.41
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 3.4
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 3.34
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 3.31
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 3.31
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 3.29
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 3.24
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 3.16
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 3.12
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 3.1
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 3.04
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 3.02
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 3.0
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 3.0
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 2.98
Differences in miRNA Detection Levels are Technology and Sequence Dependent 2.98
miRNAs affected by antagomiR-17 treatment 2.96
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 2.92
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 2.92
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 2.87
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 2.79
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 2.78
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 2.76
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 2.76
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 2.73
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 2.73
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 2.7
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 2.67
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 2.64
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 2.62
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 2.59
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 2.55
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 2.54
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 2.47
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 2.47
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 2.46
Identification of differentially expressed genes between senescence and senescence bypass cells 2.42
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 2.4
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 2.38
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 2.38
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 2.36
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 2.36
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 2.34
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 2.34
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 2.3
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 2.29
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 2.29
BET bromodomain inhibition 2.28
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 2.28
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 2.25
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 2.25
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 2.24
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 2.24
Determining mRNA half-lives on a transcriptome-wide scale 2.1
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 2.05
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 2.04
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 2.04
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 1.96
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 1.94
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 1.94
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 1.9
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 1.89
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 1.89
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 1.83
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 1.78
JAK dependent survival of ALK- ALCL 1.76
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 1.74
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 1.74
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 1.74
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 1.7
The bromodomain protein BRD4 regulates splicing during heat shock 1.69
DAOY-Notch1/Notch2 knockout: transcriptome comparison 1.68
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 1.66
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 1.66
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 1.66
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 1.62
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 1.57
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 1.48
A code of mono-phosphorylation modulates the function of RB. 1.48
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 1.46
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 1.46
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 1.4
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 1.38
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 1.29
Gene expression profile of CRC-derived HILEC 1.27
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 1.26
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 1.26
Genome-wide Analysis of Chromatin Interactions in Human Cells 1.24
Dermal endothelial cells of type 2 diabetic patients 1.23
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 1.19
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 1.17
Gene expression profile in breast cancer cells 1.16
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.16
Gene expression of collecting duct carcinoma of the kidney 1.13
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 1.11
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 1.11
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 1.09
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.07
Metabolism as an early predictor of DPSCs aging 1.0
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 0.99
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 0.95
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 0.94
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 0.92
Deep RNA sequencing of the human placental transcriptome 0.89
RNA-seq of MDA-MB-231 cells with TET1 knockout 0.83
The effect of insulin on mRNA transcription of human pluripotent stem cells 0.73
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.68
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.65
H1609088 Human RNA-Sequencing 0.64
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.62
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.53
Gene expression analysis of breast cancer cell-lines 0.53
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 0.5
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.44
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 0.4
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.38
RNA-seq of IL-4 stimulated human keratinocytes 0.36
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.34
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.34
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 0.33
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.31
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 0.26
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.26
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 0.22
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.2
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 0.18
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.14
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.05


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation